Logo image of SRAD

SPORTRADAR GROUP AG-A (SRAD) Stock Fundamental Analysis

NASDAQ:SRAD - Nasdaq - CH1134239669 - Common Stock - Currency: USD

28.44  +0.6 (+2.16%)

After market: 28.193 -0.25 (-0.87%)

Fundamental Rating

6

We assign a fundamental rating of 6 out of 10 to SRAD. SRAD was compared to 131 industry peers in the Hotels, Restaurants & Leisure industry. While SRAD has a great health rating, its profitability is only average at the moment. SRAD is not priced too expensively while it is growing strongly. Keep and eye on this one! These ratings would make SRAD suitable for growth investing!


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

In the past year SRAD was profitable.
In the past year SRAD had a positive cash flow from operations.
In the past 5 years SRAD has always been profitable.
Each year in the past 5 years SRAD had a positive operating cash flow.
SRAD Yearly Net Income VS EBIT VS OCF VS FCFSRAD Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 100M 200M 300M

1.2 Ratios

Looking at the Return On Assets, with a value of 2.32%, SRAD is in line with its industry, outperforming 50.38% of the companies in the same industry.
Looking at the Return On Equity, with a value of 6.05%, SRAD is in the better half of the industry, outperforming 61.07% of the companies in the same industry.
The Return On Invested Capital of SRAD (4.33%) is comparable to the rest of the industry.
The Average Return On Invested Capital over the past 3 years for SRAD is significantly below the industry average of 15.74%.
The last Return On Invested Capital (4.33%) for SRAD is above the 3 year average (3.32%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 2.32%
ROE 6.05%
ROIC 4.33%
ROA(3y)1.27%
ROA(5y)1.22%
ROE(3y)3.04%
ROE(5y)3.99%
ROIC(3y)3.32%
ROIC(5y)3.53%
SRAD Yearly ROA, ROE, ROICSRAD Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 2 4 6 8

1.3 Margins

SRAD has a Profit Margin (5.12%) which is comparable to the rest of the industry.
SRAD's Profit Margin has been stable in the last couple of years.
Looking at the Operating Margin, with a value of 10.79%, SRAD is in line with its industry, outperforming 57.25% of the companies in the same industry.
In the last couple of years the Operating Margin of SRAD has remained more or less at the same level.
SRAD has a Gross Margin of 73.07%. This is amongst the best in the industry. SRAD outperforms 90.08% of its industry peers.
In the last couple of years the Gross Margin of SRAD has declined.
Industry RankSector Rank
OM 10.79%
PM (TTM) 5.12%
GM 73.07%
OM growth 3Y8.52%
OM growth 5Y-0.79%
PM growth 3Y11.19%
PM growth 5Y0.07%
GM growth 3Y-2.3%
GM growth 5Y-2.62%
SRAD Yearly Profit, Operating, Gross MarginsSRAD Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 20 40 60 80

7

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), SRAD is destroying value.
Compared to 1 year ago, SRAD has more shares outstanding
SRAD has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, SRAD has an improved debt to assets ratio.
SRAD Yearly Shares OutstandingSRAD Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M
SRAD Yearly Total Debt VS Total AssetsSRAD Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B

2.2 Solvency

An Altman-Z score of 3.59 indicates that SRAD is not in any danger for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 3.59, SRAD is in the better half of the industry, outperforming 78.63% of the companies in the same industry.
The Debt to FCF ratio of SRAD is 0.33, which is an excellent value as it means it would take SRAD, only 0.33 years of fcf income to pay off all of its debts.
With an excellent Debt to FCF ratio value of 0.33, SRAD belongs to the best of the industry, outperforming 92.37% of the companies in the same industry.
SRAD has a Debt/Equity ratio of 0.04. This is a healthy value indicating a solid balance between debt and equity.
SRAD has a better Debt to Equity ratio (0.04) than 83.97% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.04
Debt/FCF 0.33
Altman-Z 3.59
ROIC/WACC0.76
WACC5.68%
SRAD Yearly LT Debt VS Equity VS FCFSRAD Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

2.3 Liquidity

A Current Ratio of 1.35 indicates that SRAD should not have too much problems paying its short term obligations.
SRAD has a Current ratio of 1.35. This is in the better half of the industry: SRAD outperforms 68.70% of its industry peers.
SRAD has a Quick Ratio of 1.35. This is a normal value and indicates that SRAD is financially healthy and should not expect problems in meeting its short term obligations.
SRAD has a Quick ratio of 1.35. This is in the better half of the industry: SRAD outperforms 72.52% of its industry peers.
Industry RankSector Rank
Current Ratio 1.35
Quick Ratio 1.35
SRAD Yearly Current Assets VS Current LiabilitesSRAD Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

9

3. Growth

3.1 Past

SRAD shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 182.57%, which is quite impressive.
Measured over the past years, SRAD shows a very strong growth in Earnings Per Share. The EPS has been growing by 21.84% on average per year.
Looking at the last year, SRAD shows a very strong growth in Revenue. The Revenue has grown by 26.09%.
SRAD shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 23.81% yearly.
EPS 1Y (TTM)182.57%
EPS 3Y38.99%
EPS 5Y21.84%
EPS Q2Q%N/A
Revenue 1Y (TTM)26.09%
Revenue growth 3Y25.4%
Revenue growth 5Y23.81%
Sales Q2Q%12.24%

3.2 Future

SRAD is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 66.45% yearly.
SRAD is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 12.65% yearly.
EPS Next Y185.2%
EPS Next 2Y101.53%
EPS Next 3Y82.38%
EPS Next 5Y66.45%
Revenue Next Year16.86%
Revenue Next 2Y16.64%
Revenue Next 3Y16.1%
Revenue Next 5Y12.65%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
SRAD Yearly Revenue VS EstimatesSRAD Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 500M 1B 1.5B 2B
SRAD Yearly EPS VS EstimatesSRAD Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 0.2 0.4 0.6 0.8

4

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 67.71 indicates a quite expensive valuation of SRAD.
The rest of the industry has a similar Price/Earnings ratio as SRAD.
When comparing the Price/Earnings ratio of SRAD to the average of the S&P500 Index (26.99), we can say SRAD is valued expensively.
With a Price/Forward Earnings ratio of 55.13, SRAD can be considered very expensive at the moment.
Compared to the rest of the industry, the Price/Forward Earnings ratio of SRAD indicates a slightly more expensive valuation: SRAD is more expensive than 62.60% of the companies listed in the same industry.
When comparing the Price/Forward Earnings ratio of SRAD to the average of the S&P500 Index (36.36), we can say SRAD is valued expensively.
Industry RankSector Rank
PE 67.71
Fwd PE 55.13
SRAD Price Earnings VS Forward Price EarningsSRAD Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of SRAD is on the same level as its industry peers.
The rest of the industry has a similar Price/Free Cash Flow ratio as SRAD.
Industry RankSector Rank
P/FCF 46.8
EV/EBITDA 16.43
SRAD Per share dataSRAD EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2 4

4.3 Compensation for Growth

SRAD's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
The decent profitability rating of SRAD may justify a higher PE ratio.
SRAD's earnings are expected to grow with 82.38% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.37
PEG (5Y)3.1
EPS Next 2Y101.53%
EPS Next 3Y82.38%

0

5. Dividend

5.1 Amount

SRAD does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

SPORTRADAR GROUP AG-A

NASDAQ:SRAD (8/6/2025, 8:00:00 PM)

After market: 28.193 -0.25 (-0.87%)

28.44

+0.6 (+2.16%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Services
GICS IndustryHotels, Restaurants & Leisure
Earnings (Last)08-05 2025-08-05/bmo
Earnings (Next)N/A N/A
Inst Owners79.07%
Inst Owner Change0.67%
Ins Owners0.52%
Ins Owner ChangeN/A
Market Cap8.50B
Analysts81.6
Price Target30.62 (7.67%)
Short Float %2.85%
Short Ratio3.33
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)20.63%
Min EPS beat(2)-100%
Max EPS beat(2)141.26%
EPS beat(4)2
Avg EPS beat(4)54.91%
Min EPS beat(4)-100%
Max EPS beat(4)278.4%
EPS beat(8)3
Avg EPS beat(8)13.27%
EPS beat(12)5
Avg EPS beat(12)-16.74%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)0.98%
Min Revenue beat(2)-0.42%
Max Revenue beat(2)2.39%
Revenue beat(4)3
Avg Revenue beat(4)2.56%
Min Revenue beat(4)-0.42%
Max Revenue beat(4)4.89%
Revenue beat(8)4
Avg Revenue beat(8)0.37%
Revenue beat(12)7
Avg Revenue beat(12)0.8%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)10.58%
PT rev (3m)11.17%
EPS NQ rev (1m)-3.55%
EPS NQ rev (3m)-3.9%
EPS NY rev (1m)-1.88%
EPS NY rev (3m)13.82%
Revenue NQ rev (1m)-0.16%
Revenue NQ rev (3m)-0.99%
Revenue NY rev (1m)0.08%
Revenue NY rev (3m)-0.91%
Valuation
Industry RankSector Rank
PE 67.71
Fwd PE 55.13
P/S 6.39
P/FCF 46.8
P/OCF 18.97
P/B 7.56
P/tB N/A
EV/EBITDA 16.43
EPS(TTM)0.42
EY1.48%
EPS(NY)0.52
Fwd EY1.81%
FCF(TTM)0.61
FCFY2.14%
OCF(TTM)1.5
OCFY5.27%
SpS4.45
BVpS3.76
TBVpS-3.35
PEG (NY)0.37
PEG (5Y)3.1
Profitability
Industry RankSector Rank
ROA 2.32%
ROE 6.05%
ROCE 5.9%
ROIC 4.33%
ROICexc 5.22%
ROICexgc N/A
OM 10.79%
PM (TTM) 5.12%
GM 73.07%
FCFM 13.66%
ROA(3y)1.27%
ROA(5y)1.22%
ROE(3y)3.04%
ROE(5y)3.99%
ROIC(3y)3.32%
ROIC(5y)3.53%
ROICexc(3y)4.06%
ROICexc(5y)5.55%
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)4.52%
ROCE(5y)4.82%
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3Y7.36%
ROICexc growth 5Y-3.96%
OM growth 3Y8.52%
OM growth 5Y-0.79%
PM growth 3Y11.19%
PM growth 5Y0.07%
GM growth 3Y-2.3%
GM growth 5Y-2.62%
F-Score7
Asset Turnover0.45
Health
Industry RankSector Rank
Debt/Equity 0.04
Debt/FCF 0.33
Debt/EBITDA 0.1
Cap/Depr 77.98%
Cap/Sales 20.03%
Interest Coverage 1.57
Cash Conversion 92.36%
Profit Quality 266.99%
Current Ratio 1.35
Quick Ratio 1.35
Altman-Z 3.59
F-Score7
WACC5.68%
ROIC/WACC0.76
Cap/Depr(3y)86.86%
Cap/Depr(5y)86.55%
Cap/Sales(3y)21.89%
Cap/Sales(5y)22.44%
Profit Quality(3y)195.32%
Profit Quality(5y)194.81%
High Growth Momentum
Growth
EPS 1Y (TTM)182.57%
EPS 3Y38.99%
EPS 5Y21.84%
EPS Q2Q%N/A
EPS Next Y185.2%
EPS Next 2Y101.53%
EPS Next 3Y82.38%
EPS Next 5Y66.45%
Revenue 1Y (TTM)26.09%
Revenue growth 3Y25.4%
Revenue growth 5Y23.81%
Sales Q2Q%12.24%
Revenue Next Year16.86%
Revenue Next 2Y16.64%
Revenue Next 3Y16.1%
Revenue Next 5Y12.65%
EBIT growth 1Y32.84%
EBIT growth 3Y36.08%
EBIT growth 5Y22.83%
EBIT Next Year117.8%
EBIT Next 3Y53.12%
EBIT Next 5Y36.1%
FCF growth 1Y877.26%
FCF growth 3Y347.38%
FCF growth 5Y21.32%
OCF growth 1Y111.14%
OCF growth 3Y38.73%
OCF growth 5Y19.31%